Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Changes in prescribing patterns in stage III colon cancer (CC) since the IDEA collaboration.
Authors
Daniel Walden
Mayo Clinic Arizona, Phoenix, AZ
Daniel Walden , Fang-Shu Ou , Joseph J. Larson , Christina Wu , Sandra Kang , Alex John Liu , Cassia R Griswold , Benjamin Edward Ueberroth , Bhamini Patel , Amber Draper , Kelley Rone , Puneet Raman , Tanios S. Bekaii-Saab , Daniel H. Ahn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
DOI
10.1200/JCO.2022.40.4_suppl.092
Abstract #
92
Poster Bd #
E4
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2014 Gastrointestinal Cancers Symposium
Cost differential among systemic therapies for colon cancer.
First Author: Hasan Nadeem
Poster
2013 Gastrointestinal Cancers Symposium
Effectiveness of capecitabine plus oxaliplatin for advanced colon cancer: A public hospital experience.
First Author: Carrie Luu
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy of adjuvant fluoropyrimidine with or without oxaliplatin therapy in older adults with mismatch repair deficient stage III colorectal cancer.
First Author: Jerod J Sears